BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugimoto M, Furuta T, Yamaoka Y. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24:1725-1732. [PMID: 20136959 DOI: 10.1111/j.1440-1746.2009.06047.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-Rodríguez M, Partida-Rodríguez O, Camorlinga-Ponce M, Flores-Luna L, Lazcano E, Gómez A, Herrera-Goepfert R, Medrano-Guzmán R, Torres J. Polymorphisms in HLA-DQ genes, together with age, sex, and Helicobacter pylori infection, as potential biomarkers for the early diagnosis of gastric cancer. Helicobacter 2017;22. [PMID: 27334226 DOI: 10.1111/hel.12326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mcneil JO, Goralski KB. Drug-Cytokine Interactions. In: Piscitelli SC, Rodvold KA, Pai MP, editors. Drug Interactions in Infectious Diseases. Totowa: Humana Press; 2011. pp. 167-201. [DOI: 10.1007/978-1-61779-213-7_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Zhang J, Sun X, Wang J, Zhang F, Li X, Han J. Association of the IL-1RN variable number of tandem repeat polymorphism and Helicobacter pylori infection: A meta-analysis. PLoS One 2017;12:e0175052. [PMID: 28384207 DOI: 10.1371/journal.pone.0175052] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Kumar S, Patel GK, Ghoshal UC. Helicobacter pylori-Induced Inflammation: Possible Factors Modulating the Risk of Gastric Cancer. Pathogens 2021;10:1099. [PMID: 34578132 DOI: 10.3390/pathogens10091099] [Reference Citation Analysis]
5 Mitchell PJ, Afzali B, Fazekasova H, Chen D, Ali N, Powell N, Lord GM, Lechler RI, Lombardi G. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells. Clin Exp Immunol. 2012;170:300-309. [PMID: 23121671 DOI: 10.1111/j.1365-2249.2012.04659.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
6 Kumar S, Kumari N, Mittal RD, Mohindra S, Ghoshal UC. Association between pro-(IL-8) and anti-inflammatory (IL-10) cytokine variants and their serum levels and H. pylori-related gastric carcinogenesis in northern India. Meta Gene 2015;6:9-16. [PMID: 26380815 DOI: 10.1016/j.mgene.2015.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
7 Hong J, Shu X, Liu D, Zhu Y, Xie C, Xie Y, Zhang K, Wang A, Xiong H, Zeng H. Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial. J Antimicrob Chemother. 2016;71:2280-2285. [PMID: 27107097 DOI: 10.1093/jac/dkw118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
8 Tian MM, Sun Y, Li ZW, Wu Y, Zhao AL, Li JY. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol 2012; 18(4): 368-374 [PMID: 22294843 DOI: 10.3748/wjg.v18.i4.368] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
9 Rech TF, Mazzoleni LE, Mazzoleni F, Francesconi CFM, Sander GB, Michita RT, Nabinger DD, Milbradt TC, Torresini RJS, Simon D. Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism. Braz J Infect Dis 2018;22:311-6. [PMID: 30048609 DOI: 10.1016/j.bjid.2018.06.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Ma J, Wu D, Hu X, Li J, Cao M, Dong W. Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis. PLoS One. 2017;12:e0176463. [PMID: 28453551 DOI: 10.1371/journal.pone.0176463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
11 Esteves LM, Bulhões SM, Branco CC, Mota FM, Paiva C, Cabral R, Vieira ML, Mota-Vieira L. Human leptospirosis: seroreactivity and genetic susceptibility in the population of São Miguel Island (Azores, Portugal). PLoS One 2014;9:e108534. [PMID: 25255143 DOI: 10.1371/journal.pone.0108534] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
12 Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G. MyD88 and its divergent toll in carcinogenesis. Trends Immunol 2013;34:379-89. [PMID: 23660392 DOI: 10.1016/j.it.2013.03.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
13 Hsieh MS, Kuo FC, Wu MC, Wang JW, Liu CJ, Chu NS, Tsai PY, Hsu PI, Wu IC, Wu JY, Wu DC, Yu FJ, Kuo CH. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. J Formos Med Assoc 2021:S0929-6646(21)00483-6. [PMID: 34836662 DOI: 10.1016/j.jfma.2021.10.011] [Reference Citation Analysis]
14 Shah SC, Tepler A, Chung CP, Suarez G, Peek RM Jr, Hung A, Roumie C, Narula N. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis. Gastroenterology 2021:S0016-5085(21)03338-2. [PMID: 34358488 DOI: 10.1053/j.gastro.2021.07.043] [Reference Citation Analysis]
15 Xue M, Zhang S, Li J, Li W, Wang D. Association of interleukin-1B gene polymorphisms at site 511 with gastroesophageal reflux disease: a meta-analysis. Esophagus 2016;13:74-9. [DOI: 10.1007/s10388-015-0498-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Auesomwang C, Maneerattanaporn M, Chey WD, Kiratisin P, Leelakusolwong S, Tanwandee T. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. J Gastroenterol Hepatol. 2018;33:1822-1828. [PMID: 29804294 DOI: 10.1111/jgh.14292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Karaca RO, Kalkisim S, Altinbas A, Kilincalp S, Yuksel I, Goktas MT, Yasar U, Bozkurt A, Babaoglu MO. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication. Basic Clin Pharmacol Toxicol 2017;120:199-206. [DOI: 10.1111/bcpt.12667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
18 Liu H, Qin Y, Yang J, Huang G, Wei X, Wang L, Li W. Helicobacter pylori Infection as a Risk Factor for Abnormal Serum Protein Levels in General Population of China. JIR 2022;Volume 15:2009-17. [DOI: 10.2147/jir.s355446] [Reference Citation Analysis]
19 Ito N, Tsujimoto H, Ueno H, Xie Q, Shinomiya N. Helicobacter pylori-Mediated Immunity and Signaling Transduction in Gastric Cancer. J Clin Med 2020;9:E3699. [PMID: 33217986 DOI: 10.3390/jcm9113699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Miftahussurur M, Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015;9:1535-1547. [PMID: 26470920 DOI: 10.1586/17474124.2015.1095089] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
21 Hagymási K, Müllner K, Herszényi L, Tulassay Z. Update on the pharmacogenomics of proton pump inhibitors. Pharmacogenomics. 2011;12:873-888. [PMID: 21692617 DOI: 10.2217/pgs.11.4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
22 Syam AF, Miftahussurur M, Makmun D, Nusi IA, Zain LH, Zulkhairi , Akil F, Uswan WB, Simanjuntak D, Uchida T. Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study. PLoS One. 2015;10:e0140186. [PMID: 26599790 DOI: 10.1371/journal.pone.0140186] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
23 Liu J, Zhang F, Zhang Z, Zheng C. Everolimus ameliorates Helicobacter pylori infection-induced inflammation in gastric epithelial cells. Bioengineered 2022;13:11361-72. [PMID: 35506423 DOI: 10.1080/21655979.2021.2018533] [Reference Citation Analysis]
24 de Zoete MR, Flavell RA. Interactions between Nod-Like Receptors and Intestinal Bacteria. Front Immunol. 2013;4:462. [PMID: 24381573 DOI: 10.3389/fimmu.2013.00462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
25 Shakhatreh MAK, Khabour OF, Alzoubi KH, BaniHani MN, Abu-Siniyeh A, Bashir NA, Sabi SH, Mahafdah M. The Influence of IL-1B Gene Polymorphisms on H. pylori Infection and Triple Treatment Response Among Jordanian Population. Appl Clin Genet 2020;13:139-45. [PMID: 32669867 DOI: 10.2147/TACG.S253778] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Suk KT, Baik SK, Kim HS, Park SM, Paeng KJ, Uh Y, Jang IH, Cho MY, Choi EH, Kim MJ. Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua Stokes) on Helicobacter pylori. Helicobacter. 2011;16:434-443. [PMID: 22059394 DOI: 10.1111/j.1523-5378.2011.00864.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
27 Belopolskaya OB, Smelaya TV, Moroz VV, Golubev AM, Salnikova LE. Clinical associations of host genetic variations in the genes of cytokines in critically ill patients. Clin Exp Immunol 2015;180:531-41. [PMID: 25619315 DOI: 10.1111/cei.12592] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
28 Pirzadeh M, Khalili N, Rezaei N. The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer. International Reviews of Immunology. [DOI: 10.1080/08830185.2020.1851371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kim DJ, Park JH, Franchi L, Backert S, Núñez G. The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells. Eur J Immunol 2013;43:2650-8. [PMID: 23818043 DOI: 10.1002/eji.201243281] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
30 Valenzuela MA, Canales J, Corvalán AH, Quest AF. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol 2015; 21(45): 12742-12756 [PMID: 26668499 DOI: 10.3748/wjg.v21.i45.12742] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
31 Sun X, Xu Y, Zhang F, Jing T, Han J, Zhang J. Association between the IL1B -31C > T polymorphism and Helicobacter pylori infection in Asian and Latin American population: A meta-analysis. Microb Pathog 2015;86:45-52. [PMID: 26188264 DOI: 10.1016/j.micpath.2015.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
32 Sugimoto M, Furuta T. Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. World J Gastroenterol 2014; 20(21): 6400-6411 [PMID: 24914361 DOI: 10.3748/wjg.v20.i21.6400] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]